HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 281, Issue 40, 29938-29948, October 6, 2006

This Article Full Text Full Text (PDF) All Versions of this Article: 281/40/29938    most recent M602237200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chuan, Y.-C. Articles by Flores-Morales, A. Search for Related Content PubMed PubMed Citation Articles by Chuan, Y.-C. Articles by Flores-Morales, A. Social Bookmarking                      What's this?

Androgen Induction of Prostate Cancer Cell Invasion Is Mediated by Ezrin^*

Yin-Choy Chuan, See-Tong Pang^¶, Angel Cedazo-Minguez^||, Gunnar Norstedt, Åke Pousette, and Amilcar Flores-Morales¹

From the Department of Molecular Medicine and Surgery, ^||Section of Experimental Geriatrics, Karolinska Institute, Neurotec, and Andrology Center, Department of Medicine, Karolinska Institute, 17176 Stockholm, Sweden and ^¶Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Tao-Yuan 333, Taiwan

Ezrin is a key signaling molecule that regulates cell survival, adhesion migration, and invasion. We have previously shown that ezrin is regulated by androgen in rat prostate and that its expression is increased in prostate cancer and in prostate intraepithelial neoplasia. We have used the androgen-sensitive cell line LNCaP-FGC to investigate the role of ezrin in androgen-induced cell invasion. We found that androgen treatment of LNCaP-FGC cells induces ezrin expression, an effect that is inhibited by the androgen receptor antagonist, bicalutamide. In addition, androgen treatment induces the phosphorylation of ezrin in Thr-567 and Tyr-353 in a sequential manner. This is mediated through protein kinase C and Src tyrosine kinase, respectively. Androgen treatment induces the translocation of both protein kinase C and ezrin to the cell membrane and their association. Inhibition of ezrin function using short interference RNA or the overexpression of T567A and Y353F-ezrin mutants significantly reduces androgen-induced Matrigel invasion but does not affect cell proliferation or cell adhesion. Matrigel invasion of the androgen-insensitive prostate cancer cell lines PC-3 and LNCaP-R is also dependent on ezrin. In summary, we have shown that androgens regulate ezrin at transcriptional and posttranscriptional levels. Hormonal regulation of ezrin phosphorylation is required for androgen-induced cell invasion.

Received for publication, March 9, 2006 , and in revised form, July 26, 2006.

^* This work was supported by grants from the foundations of the Karolinska Institute, Cancerfonden (45576-B01-01XAB), and Swedish Research Council (529-2002-6766). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ To whom correspondence should be addressed: Dept. of Molecular Medicine and Surgery, CMM L8:01, Karolinska Hospital, 17176 Stockholm, Sweden. Tel.: 46-8-51772089; Fax: 46-8-51556180; E-mail: Amilcar.Flores{at}cmm.ki.se.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Pagliocca, P. Hegyi, V. Venglovecz, S. A. Rackstraw, Z. Khan, G. Burdyga, T. C. Wang, R. Dimaline, A. Varro, and G. J. Dockray Identification of ezrin as a target of gastrin in immature mouse gastric parietal cells Exp Physiol, November 1, 2008; 93(11): 1174 - 1189. [Abstract] [Full Text] [PDF]

				O. Gautschi, C. G. Tepper, P. R. Purnell, Y. Izumiya, C. P. Evans, T. P. Green, P. Y. Desprez, P. N. Lara, D. R. Gandara, P. C. Mack, et al. Regulation of Id1 Expression by Src: Implications for Targeting of the Bone Morphogenetic Protein Pathway in Cancer Cancer Res., April 1, 2008; 68(7): 2250 - 2258. [Abstract] [Full Text] [PDF]

				H. Neuwirt, M. Puhr, I. T Cavarretta, M. Mitterberger, A. Hobisch, and Z. Culig Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretion Endocr. Relat. Cancer, December 1, 2007; 14(4): 1007 - 1019. [Abstract] [Full Text] [PDF]

				H. Zhang, J. Wang, B. Pang, R.-x. Liang, S. Li, P.-t. Huang, R. Wang, L. W.K. Chung, H. E. Zhau, C. Huang, et al. PC-1/PrLZ Contributes to Malignant Progression in Prostate Cancer Cancer Res., September 15, 2007; 67(18): 8906 - 8913. [Abstract] [Full Text] [PDF]

				L. Zhu, R. Zhou, S. Mettler, T. Wu, A. Abbas, J. Delaney, and J. G. Forte High turnover of ezrin T567 phosphorylation: conformation, activity, and cellular function Am J Physiol Cell Physiol, September 1, 2007; 293(3): C874 - C884. [Abstract] [Full Text] [PDF]

				L.E. Diaz, Y-C. Chuan, M. Lewitt, L. Fernandez-Perez, S. Carrasco-Rodriguez, M. Sanchez-Gomez, and A. Flores-Morales IGF-II regulates metastatic properties of choriocarcinoma cells through the activation of the insulin receptor Mol. Hum. Reprod., August 1, 2007; 13(8): 567 - 576. [Abstract] [Full Text] [PDF]